As evidenced by the reduction of MN pathology and enhanced NMJ structure and function in different SMA models overexpressing PLS3, an emphasis on endocytosis may result in promising combination therapies specifically targeting milder forms of SMA; in severe cases, however, the effectiveness of such approaches has remained limited [105]. Here, PLS3 is linked to proximal spinal muscular atrophy.